Lisa Kuhns,

Lisa Kuhns, PhD is a researcher who has contributed to various studies on diabetes, thyroid dysfunction, mental health in long COVID patients, vitamin E intake and its relation to allergic contact dermatitis and glucose sensor systems in diabetic patients among others. Her work also includes assessing the prevalence of hyperuricemia and metabolic syndrome among the US population, evaluating trends in central line-associated bloodstream infections, analyzing data from NHANES to determine dietary vitamin E intake's relationship with thyroid dysfunction. She has conducted systematic reviews and meta-analyses on topics such as the risk for lower extremity amputation among patients with type 2 diabetes, the relationship between diabetes and FSH levels in postmenopausal women, the association between allergic contact dermatitis and glucose sensor systems in diabetic patients, factors associated with bone erosion among patients with gout and tophi. She has also explored relationships such as that between intra-articular mineralization and cartilage worsening over 2 years among older patients at risk for osteoarthritis, the incidence and predictors of complications in patients with gram-negative bloodstream infections, bone mineral density among postmenopausal women with osteoporosis or osteopenia after biphosphate treatment discontinuation. Her work also includes assessing mental health, gender dysphoria and minority stress after 1 year of gender-affirming hormone therapy among transgender adolescents, the incidence and predictors of complications in patients with gram-negative bloodstream infections, the relationship between COVID-19 vaccination status and risk for long COVID among patients infected before and during the Omicron period. She has also investigated the association between dementia and SGLT2 inhibitor use among diabetic patients with atrial fibrillation, risks for nonthyroidal autoimmune diseases among patients with Graves disease, niacin intake's relationship to knee pain and physical function in patients with knee osteoarthritis, effectiveness of influenza vaccination during pregnancy on the risk for influenza-associated hospitalizations among infants younger than 6 months. She has also evaluated the appropriateness of antimicrobial therapy and predictors of mortality among inpatients with negative blood cultures, antibody responses and neutralization activity between children and adults in the 6 months following COVID-19 vaccination, clinical and imaging data, outcomes, disease course after treatment initiation among children with chronic nonbacterial osteomyelitis.

42%

The Daily's Verdict

This author has a poor reputation for journalistic standards and is not considered a reliable news source.

Bias

80%

Examples:

  • Among those dispensed a GLP-1RA, 8495 also received an antidepressant (aOR, 1.44; 99% CI, 1.38-1.50).
  • Case-control analyses revealed that 2.11% of individuals dispensed antidepressants in 2022 had received a GLP-1RA between 2012 and 2021 (aOR, 1.52; 99% CI, 1.46-1.59).
  • Longitudinal analyses showed an increased odds for being dispensed an antidepressant following the dispensing of a GLP-1RA (aHR, 1.19; 99% CI, 1.12-1.27).

Conflicts of Interest

0%

Examples:

No current examples available.

Contradictions

0%

Examples:

No current examples available.

Deceptions

30%

Examples:

  • The primary outcome was the odds of receiving an antidepressant prescription, including selective serotonin reuptake inhibitors and non-selective monoamine reuptake inhibitors.

Recent Articles

GLP-1 Receptor Agonists and Psychiatric Issues: Two Cases of Depression and Suicidal Ideation Linked to Semaglutide

GLP-1 Receptor Agonists and Psychiatric Issues: Two Cases of Depression and Suicidal Ideation Linked to Semaglutide

Broke On: Wednesday, 08 May 2024 Two case studies presented at the American Psychiatric Association annual meeting suggest a potential link between GLP-1 receptor agonists like semaglutide and psychiatric issues, including depression and suicidal ideation. The medication, which acts on the brain to modulate food intake and reward, has been associated with approximately 60 reported cases of suicidal ideation since 2018. Further research is needed to identify specific proteins or enzymes that may exacerbate psychological conditions and contribute to these risks.